Pharm-Olam is now Allucent. Learn More
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
“Adaptive designs” in clinical research refer to study designs where certain features are left flexible on purpose, so they can...
A liquid biopsy is a testing technique where a sample of blood is analysed for cancer cells from a tumour that is circulating in...
Oncology is a multi-faceted field of study and a popular one. Cancer clinical trials account for more than 19% of the research...
Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened...
Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...
Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions for rare diseases, oncology, hematology,...
Cohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it. Pharm-Olam...
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.